Live Quote · LSEPHP.LReal Estate · REIT - Healthcare Facilities

Primary Health Properties PLC

$96.05▲ 0.73%(+$0.70)

MKT CAP $1.29BLAST EARNINGS Jul 30, 2026

50%

Bullish

50%

Bullish

TickerSpark Score

75/100

▌ Solid

84

Valuation

80

Profitability

100

Growth

60

Health

50

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a PHP.L research report →

Price Chart

+3.22% · this period

52-Week Range39% of range

Low

$87.40

Current

$96.05

High

$109.60

Earnings Calls · PHP.L

Earnings call summaries

Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.

PHP reported a strong first half with 9% adjusted EPS growth, cost synergies nearly complete, and deleveraging on track as it advances a private hospital JV to repay bridge debt.· July 30, 2026

Key Takeaways

Adjusted EPS rose 9% to 3.8p, supported by a full 6-month Assura contribution, rent growth, and cost discipline.
Adjusted earnings increased to GBP 98 million; the portfolio stayed near full occupancy at 99% and adjusted NTA was unchanged at 104p.
Over 92% of the identified GBP 9 million cost synergies have been delivered, taking the EPRA cost ratio down to 8.7% from around 10%.
The company expects the GBP 0.7 billion private hospital JV to close in the next few weeks and use proceeds to repay the remaining bridge facility.
Management said rental evidence is improving, with rent review uplifts of 6% in the period and annualized growth of 3.2%
results":"Adjusted earnings increased to GBP 98 million, and adjusted EPS increased 9% to 3.8p for the first half. Like-for-like rental growth added GBP 4 million of income, with rent reviews delivering an annualized growth rate of 3.2% and open-market reviews up 6.3% over previous passing rent. The portfolio produced a GBP 18 million valuation surplus, while the investment portfolio remained GBP 6 billion and adjusted NTA was unchanged at 104p per share. EPRA cost ratio fell to 8.7% from around 10%, and the group said over GBP 8 million, or 92%, of the GBP 9 million cost-saving synergies had been delivered. On financing, GBP 1.2 billion has been refinanced, leaving just under GBP 260 million outstanding bridge debt; average cost of debt was 3.8% and is expected to fall to 3.5% in the second half. Management reiterated 2026 projected dividend guidance of 7.3p, fully covered, and expects further deleveraging through the private hospital JV and other disposals, with LTV moving into the low 50s short term and below 50% as a future target.
ceo":"Mark Davies emphasized that the Assura merger is now translating into operational and strategic gains, with integration nearly complete, synergies largely delivered, and financing steps progressing on schedule. He framed the business as an income compounder with secure, recurring cash flows, over 80% of future income government-backed, and a long runway for growth through rent reviews, asset management, development, and joint ventures. His tone was confident and upbeat, repeatedly saying the plans remain on track and that the company is excited about the private hospital JV and neighborhood health center opportunities.","cfo":"Richard Howell focused on the hard financial outcomes: adjusted earnings of GBP 98 million, adjusted EPS of 3.8p, an EPRA cost ratio of 8.7%, and a portfolio valuation surplus of GBP 18 million. He highlighted that GBP 1.2 billion of debt has been refinanced, the remaining bridge debt is just under GBP 260 million, the average cost of debt is 3.8%, and liquidity headroom is GBP 300 million after capital commitments. He also said rent review activity is running ahead of prior guidance at 3.2% annualized, with more synergy benefits still expected in H2, especially from property costs and internalizing Assura facilities management.","qanda":"Analysts focused on leverage, the path to investment grade, disposal pricing relative to NAV, and whether more cost savings can come from management actions beyond scale. Management said investment-grade credit status is driven more by net debt to EBITDA than by LTV alone, and noted Fitch had reconfirmed Assura’s BBB+ rating with a negative outlook that could improve as deleveraging continues. On disposals, they said they are confident about selling assets into the JVs at values the market will not be disappointed with, but declined to give exact pricing before completion. They also said more synergy benefit should emerge in H2, particularly from property costs and recently internalized facilities management.","bull":"The call pointed to multiple sources of momentum: rent reviews are producing above-guidance growth, cost synergies are mostly in hand, and the enlarged portfolio is benefiting from scale and a lower funding margin. Management also described strong demand for healthcare infrastructure, 99% occupancy, and a pipeline of capital-light development opportunities that can generate fees and rental evidence. The private hospital JV and USS primary care JV were presented as both deleveraging tools and long-term growth partnerships.","bear":"The main risks discussed were leverage and valuation sensitivity, especially with a cost of debt that still exceeds current net yields and with LTV temporarily above target. Management acknowledged that if all debt had to be refinanced at today’s rates, the economics would be challenging, and they are relying on future JV proceeds, disposals, and rental growth to improve metrics. The private hospital JV is still in due diligence, so completion and exact proceeds remain pending, and more work is needed to convert stronger rental evidence into portfolio-wide rent and valuation gains."}]}]}]} 〖EOF〗}]}]}ൾ``,```}]}]}}]}]}]}]}`````】]```񎧡}]}]}]}]}]}]}]}]}]}]}]}

AI summary of the company's earnings call · Paraphrased · Not investment advice

Primary Health Properties PLC

Price Chart

About the company

Get TickerSpark's AI analysis on PHP.L

Similar companies

Earnings call summaries

Held by 295 ETFs

Our PHP.L coverage

No research on PHP.L yet